Altre lingue Hikma Pharmaceuticals PLC

Azioni

HIK

GB00B0LCW083

Prodotti farmaceutici

Mercato chiuso - London S.E. Altri mercati azionari 17:35:07 20/01/2026			Variaz. 5gg	Var. 1 gen.
1.527,00 ^GBX	-1,04%		-0,72%	-1,48%

19/01	Hikma lancia Enoby e Xtrenbo come riferimenti rispettivamente a Prolia e Xgeva	RE
16/01	La Corte Suprema degli Stati Uniti esaminerà la controversia sui brevetti "skinny label" che coinvolge Amarin	RE

Altre lingue

19/01	Hikma announces launch of Enoby and Xtrenbo referencing Prolia and Xgeva respectively
19/01	Hikma launches Enoby and Xtrenbo referencing Prolia and Xgeva respectively
19/01	Hikma Pharmaceuticals : announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect...
16/01	US Supreme Court to hear 'skinny label' patent fight involving Amarin
15/01	Hikma Pharmaceuticals : achieves B scores in Climate Change and Water Security in 2025 CDP assessment
09/01	Berenberg raises M&S; BofA cuts Barratt Redrow
09/01	Hikma Pharmaceuticals faces tougher path to re-rating
07/01	Hikma Pharmaceuticals : Exploring partnership opportunities with Hikma Pharmaceuticals
07/01	Berenberg raises Vodafone; Barclays cuts Hikma
07/01	FTSE 100 retreats from high as oil firms fall
07/01	Reckitt proposes GBP1.6 billion special dividend
17/12	Hikma Pharmaceuticals : full year 2025 aide memoire
15/12	FTSE 100 makes headway ahead of likely BoE cut
15/12	London Shares Start Week Higher Ahead of Inflation Data, Monetary Policy Move
15/12	Global markets live: iRobot, Cencora, Franklin Resources, Sanofi, Enel…
15/12	Hikma Pharmaceuticals : Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy
15/12	Hikma Pharmaceuticals plc Announces Board Changes, Effective December 15, 2025
15/12	Hikma Pharmaceuticals PLC Announces Riad Mishlawi Step Down as Chief Executive Officer
15/12	FTSE rises as miners lift stocks
15/12	Stocks up ahead of busy week for central banks
15/12	UK's Hikma CEO steps down, chairman takes helm until successor appointed
15/12	Hikma Pharmaceuticals CEO replaced by former CEO after guidance cut
15/12	Hikma Pharmaceuticals CEO Steps Down; Executive Chairman Named Successor
15/12	Hikma CEO exits; DBAY to vote against TT deal
15/12	Hikma CEO Riad Mishlawi steps down

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Filtri

Ultime notizie

Hikma Pharmaceuticals affronta un percorso più difficile verso una rivalutazione

09 gennaio 2026 alle 10:11